Literature DB >> 21506741

A common MUC5B promoter polymorphism and pulmonary fibrosis.

Max A Seibold1, Anastasia L Wise, Marcy C Speer, Mark P Steele, Kevin K Brown, James E Loyd, Tasha E Fingerlin, Weiming Zhang, Gunnar Gudmundsson, Steve D Groshong, Christopher M Evans, Stavros Garantziotis, Kenneth B Adler, Burton F Dickey, Roland M du Bois, Ivana V Yang, Aretha Herron, Dolly Kervitsky, Janet L Talbert, Cheryl Markin, Joungjoa Park, Anne L Crews, Susan H Slifer, Scott Auerbach, Michelle G Roy, Jia Lin, Corinne E Hennessy, Marvin I Schwarz, David A Schwartz.   

Abstract

BACKGROUND: The mutations that have been implicated in pulmonary fibrosis account for only a small proportion of the population risk.
METHODS: Using a genomewide linkage scan, we detected linkage between idiopathic interstitial pneumonia and a 3.4-Mb region of chromosome 11p15 in 82 families. We then evaluated genetic variation in this region in gel-forming mucin genes expressed in the lung among 83 subjects with familial interstitial pneumonia, 492 subjects with idiopathic pulmonary fibrosis, and 322 controls. MUC5B expression was assessed in lung tissue.
RESULTS: Linkage and fine mapping were used to identify a region of interest on the p-terminus of chromosome 11 that included gel-forming mucin genes. The minor-allele of the single-nucleotide polymorphism (SNP) rs35705950, located 3 kb upstream of the MUC5B transcription start site, was present at a frequency of 34% among subjects with familial interstitial pneumonia, 38% among subjects with idiopathic pulmonary fibrosis, and 9% among controls (allelic association with familial interstitial pneumonia, P=1.2×10(-15); allelic association with idiopathic pulmonary fibrosis, P=2.5×10(-37)). The odds ratios for disease among subjects who were heterozygous and those who were homozygous for the minor allele of this SNP were 6.8 (95% confidence interval [CI], 3.9 to 12.0) and 20.8 (95% CI, 3.8 to 113.7), respectively, for familial interstitial pneumonia and 9.0 (95% CI, 6.2 to 13.1) and 21.8 (95% CI, 5.1 to 93.5), respectively, for idiopathic pulmonary fibrosis. MUC5B expression in the lung was 14.1 times as high in subjects who had idiopathic pulmonary fibrosis as in those who did not (P<0.001). The variant allele of rs35705950 was associated with up-regulation in MUC5B expression in the lung in unaffected subjects (expression was 37.4 times as high as in unaffected subjects homozygous for the wild-type allele, P<0.001). MUC5B protein was expressed in lesions of idiopathic pulmonary fibrosis.
CONCLUSIONS: A common polymorphism in the promoter of MUC5B is associated with familial interstitial pneumonia and idiopathic pulmonary fibrosis. Our findings suggest that dysregulated MUC5B expression in the lung may be involved in the pathogenesis of pulmonary fibrosis. (Funded by the National Heart, Lung, and Blood Institute and others.).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21506741      PMCID: PMC3379886          DOI: 10.1056/NEJMoa1013660

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  30 in total

Review 1.  American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

2.  A mutation in the surfactant protein C gene associated with familial interstitial lung disease.

Authors:  L M Nogee; A E Dunbar; S E Wert; F Askin; A Hamvas; J A Whitsett
Journal:  N Engl J Med       Date:  2001-02-22       Impact factor: 91.245

3.  Merlin--rapid analysis of dense genetic maps using sparse gene flow trees.

Authors:  Gonçalo R Abecasis; Stacey S Cherny; William O Cookson; Lon R Cardon
Journal:  Nat Genet       Date:  2001-12-03       Impact factor: 38.330

4.  Differential regulation of airway mucin gene expression and mucin secretion by extracellular nucleotide triphosphates.

Authors:  Y Chen; Y H Zhao; R Wu
Journal:  Am J Respir Cell Mol Biol       Date:  2001-10       Impact factor: 6.914

5.  Haploview: analysis and visualization of LD and haplotype maps.

Authors:  J C Barrett; B Fry; J Maller; M J Daly
Journal:  Bioinformatics       Date:  2004-08-05       Impact factor: 6.937

6.  Characterization of human mucin 5B gene expression in airway epithelium and the genomic clone of the amino-terminal and 5'-flanking region.

Authors:  Y Chen; Y H Zhao; Y P Di; R Wu
Journal:  Am J Respir Cell Mol Biol       Date:  2001-11       Impact factor: 6.914

Review 7.  Idiopathic pulmonary fibrosis.

Authors:  T J Gross; G W Hunninghake
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

8.  Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial.

Authors:  Talmadge E King; Carlo Albera; Williamson Z Bradford; Ulrich Costabel; Phil Hormel; Lisa Lancaster; Paul W Noble; Steven A Sahn; Javier Szwarcberg; Michiel Thomeer; Dominique Valeyre; Roland M du Bois
Journal:  Lancet       Date:  2009-06-29       Impact factor: 79.321

9.  Signal pathway of 17beta-estradiol-induced MUC5B expression in human airway epithelial cells.

Authors:  Hye Joung Choi; Yoo-Sam Chung; Hyun Jik Kim; Uk Yeol Moon; Yeon Ho Choi; Isabelle Van Seuningen; Seung Joon Baek; Ho-Geun Yoon; Joo-Heon Yoon
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-07       Impact factor: 6.914

10.  Hyaluronan fragments/CD44 mediate oxidative stress-induced MUC5B up-regulation in airway epithelium.

Authors:  S Marina Casalino-Matsuda; Maria E Monzon; Anthony J Day; Rosanna M Forteza
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-28       Impact factor: 6.914

View more
  407 in total

1.  Toll interacting protein protects bronchial epithelial cells from bleomycin-induced apoptosis.

Authors:  Xiaoyun Li; Sharon E Kim; Ting-Yun Chen; Juan Wang; Xia Yang; Tracy Tabib; Jiangning Tan; Brandon Guo; Sonia Fung; Jing Zhao; John Sembrat; Mauricio Rojas; Sruti Shiva; Robert Lafyatis; Claudette St Croix; Jonathan K Alder; Y Peter Di; Daniel J Kass; Yingze Zhang
Journal:  FASEB J       Date:  2020-06-28       Impact factor: 5.191

Review 2.  Human Fibrosis: Is There Evidence for a Genetic Predisposition in Musculoskeletal Tissues?

Authors:  Louis Dagneaux; Aaron R Owen; Jacob W Bettencourt; Jonathan D Barlow; Peter C Amadio; Jean P Kocher; Mark E Morrey; Joaquin Sanchez-Sotelo; Daniel J Berry; Andre J van Wijnen; Matthew P Abdel
Journal:  J Arthroplasty       Date:  2020-06-04       Impact factor: 4.757

Review 3.  New roles of carboxypeptidase E in endocrine and neural function and cancer.

Authors:  Niamh X Cawley; William C Wetsel; Saravana R K Murthy; Joshua J Park; Karel Pacak; Y Peng Loh
Journal:  Endocr Rev       Date:  2012-03-07       Impact factor: 19.871

Review 4.  Genetic interstitial lung disease.

Authors:  Megan Stuebner Devine; Christine Kim Garcia
Journal:  Clin Chest Med       Date:  2011-12-06       Impact factor: 2.878

5.  Revealing the Secrets of Idiopathic Pulmonary Fibrosis.

Authors:  Richard K Albert; David A Schwartz
Journal:  N Engl J Med       Date:  2019-01-03       Impact factor: 91.245

6.  The mitochondrial cardiolipin remodeling enzyme lysocardiolipin acyltransferase is a novel target in pulmonary fibrosis.

Authors:  Long Shuang Huang; Biji Mathew; Haiquan Li; Yutong Zhao; Shwu-Fan Ma; Imre Noth; Sekhar P Reddy; Anantha Harijith; Peter V Usatyuk; Evgeny V Berdyshev; Naftali Kaminski; Tong Zhou; Wei Zhang; Yanmin Zhang; Jalees Rehman; Sainath R Kotha; Travis O Gurney; Narasimham L Parinandi; Yves A Lussier; Joe G N Garcia; Viswanathan Natarajan
Journal:  Am J Respir Crit Care Med       Date:  2014-06-01       Impact factor: 21.405

Review 7.  The diagnosis and treatment of idiopathic pulmonary fibrosis.

Authors:  Jürgen Behr
Journal:  Dtsch Arztebl Int       Date:  2013-12-23       Impact factor: 5.594

8.  Association between MUC5B and TERT polymorphisms and different interstitial lung disease phenotypes.

Authors:  Rongrong Wei; Chong Li; Min Zhang; Yava L Jones-Hall; Jamie L Myers; Imre Noth; Wanqing Liu
Journal:  Transl Res       Date:  2013-12-17       Impact factor: 7.012

9.  Endogenous airway mucins carry glycans that bind Siglec-F and induce eosinophil apoptosis.

Authors:  Takumi Kiwamoto; Toshihiko Katoh; Michael Tiemeyer; Bruce S Bochner; Christopher M Evans; William J Janssen; Mary E Brummet; Sherry A Hudson; Zhou Zhu
Journal:  J Allergy Clin Immunol       Date:  2014-12-12       Impact factor: 10.793

10.  Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension.

Authors:  Rachel Damico; Todd M Kolb; Lidenys Valera; Lan Wang; Traci Housten; Ryan J Tedford; David A Kass; Nicholas Rafaels; Li Gao; Kathleen C Barnes; Raymond L Benza; James L Rand; Rizwan Hamid; James E Loyd; Ivan M Robbins; Anna R Hemnes; Wendy K Chung; Eric D Austin; M Bradley Drummond; Stephen C Mathai; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2015-01-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.